DeFilipp, Zachariah ; Couriel, Daniel R. ; Lazaryan, Aleksandr ; Bhatt, Vijaya Raj ; Buxbaum, Nataliya P. 
; Alousi, Amin M. ; Olivieri, Attilio ; Pulanic, Drazen ; Halter, Joerg P. ; Henderson, Lori A. ; Zeiser, Robert ; Gooley, Ted A. ; MacDonald, Kelli P.A. ; Wolff, Daniel ; Schultz, Kirk R. ; Paczesny, Sophie ; Inamoto, Yoshihiro ; Cutler, Corey S. ; Kitko, Carrie L. ; Pidala, Joseph A. ; Lee, Stephanie J. ; Socie, Gerard ; Sarantopoulos, Stefanie ; Pavletic, Steven Z. ; Martin, Paul J. ; Blazar, Bruce R. ; Greinix, Hildegard T.
; Alousi, Amin M. ; Olivieri, Attilio ; Pulanic, Drazen ; Halter, Joerg P. ; Henderson, Lori A. ; Zeiser, Robert ; Gooley, Ted A. ; MacDonald, Kelli P.A. ; Wolff, Daniel ; Schultz, Kirk R. ; Paczesny, Sophie ; Inamoto, Yoshihiro ; Cutler, Corey S. ; Kitko, Carrie L. ; Pidala, Joseph A. ; Lee, Stephanie J. ; Socie, Gerard ; Sarantopoulos, Stefanie ; Pavletic, Steven Z. ; Martin, Paul J. ; Blazar, Bruce R. ; Greinix, Hildegard T. 
Zusammenfassung
Positive results from recent clinical trials have significantly expanded current therapeutic options for patients with chronic graft-versus-host disease (GVHD). However, new insights into the associations between clinical characteristics of chronic GVHD, pathophysiologic mechanisms of disease, and the clinical and biological effects of novel therapeutic agents are required to allow for a more ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric